App-icoon van AgingResearch.News: Longevity

The fastest way to know what really works in longevity

Door PAPERFOOT AI PTE. LTD. · Sociaal
Debuts-score 76NieuwBeoordeel als eerste

Waarom we dit verwachten: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

AgingResearch.News: Longevity screenshot 1AgingResearch.News: Longevity screenshot 2AgingResearch.News: Longevity screenshot 3AgingResearch.News: Longevity screenshot 4AgingResearch.News: Longevity screenshot 5

Vergelijkbare Sociaal-apps

Bekijk de beste

Kort samengevat

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Samenvatting door Debuts, gebaseerd op de vermelding in de App Store.

Over deze app

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Vragen over AgingResearch.News: Longevity

Wat is AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
Is AgingResearch.News: Longevity gratis?
Ja. AgingResearch.News: Longevity is gratis te downloaden.
Op welke apparaten werkt AgingResearch.News: Longevity?
AgingResearch.News: Longevity werkt op iPhone, iPad.
In welke talen is AgingResearch.News: Longevity beschikbaar?
AgingResearch.News: Longevity is beschikbaar in 11 talen, waaronder Duits, Engels, Spaans, Frans, Italiaans, Japans.
Wie maakt AgingResearch.News: Longevity?
AgingResearch.News: Longevity is gemaakt door PAPERFOOT AI PTE. LTD.. De leeftijdsclassificatie in de App Store is 12+.
Wat zijn alternatieven voor AgingResearch.News: Longevity?
Vergelijkbare apps op Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Zo beoordelen mensen de app

Log in om deze app te beoordelen. Eerlijk is wat telt.

Nog geen beoordelingen. Heb je de app geprobeerd? Beoordeel hem als eerste.

Vindbaarheidssignalen

Hoe AI en mensen AgingResearch.News: Longevity ontdekken op Debuts
Klaar voor AIGedeeltelijk
78% beschreven zodat AI de app kan matchen
Nu vindbaarLiveGestructureerde data op deze pagina en de Debuts API

Vertel ons wat je leuk vindt. We mailen alleen als er iets nieuws past, en makers voegen vaak een deal toe voor testers.

Wat voor apps
Op mijn
Toon alleen
Hoe vaak
We sturen je een link ter bevestiging. Je ontvangt niets voordat je erop klikt.